Understanding Chronic Lymphocytic Leukemia
Recruiting
- Conditions
- Chronic Lymphocytic Leukemia
- Registration Number
- NCT04028531
- Lead Sponsor
- Dana-Farber Cancer Institute
- Brief Summary
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
- Detailed Description
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2750
Inclusion Criteria
- New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- Any low grade lymphoproliferative disorder
- Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia 20 years Exploratory science to better understand Chronic Lymphocytic Leukemia
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dana Farber Cancer Institute
🇺🇸Boston, Massachusetts, United States